GV

Geeta Vinodkumar Jariwala

Active Director Director/Designated Partner DIN 11877703
DIN 11877703 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Geeta Vinodkumar Jariwala

Geeta Vinodkumar Jariwala is a Director/Designated Partner at Cardionova Pharma Private Limited (since 2026).

DIN 11877703
Primary Designation Director/Designated Partner
First Appointment 17 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cardionova Pharma Private Limited U46497TS2026PTC220838
Director/Designated Partner17 Aug 20262026Active

Board colleagues of Geeta Vinodkumar Jariwala

NameDINCompanyDesignation
Shilpa Pankaj Jariwala11877702Cardionova Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cardionova Pharma Private Limited
Premium access

Shareholding and investment profile for Geeta Vinodkumar Jariwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geeta Vinodkumar Jariwala

Geeta Vinodkumar Jariwala currently holds 1 directorship: Cardionova Pharma Private Limited (Director/Designated Partner, since 17 Aug 2026).

Geeta Vinodkumar Jariwala was first appointed on 17 Aug 2026 as Director/Designated Partner at Cardionova Pharma Private Limited.

The current boards of Geeta Vinodkumar Jariwala's companies include Shilpa Pankaj Jariwala (Cardionova Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available